期刊
ANNALS OF ONCOLOGY
卷 24, 期 3, 页码 734-741出版社
OXFORD UNIV PRESS
DOI: 10.1093/annonc/mds513
关键词
microRNA-21; microRNA-101; microRNA-155; outcome; pancreatic intraductal papillary mucinous neoplasms
类别
资金
- Netherlands Organization for Scientific Research [91611046]
- VENI
- AIRC - Marie Curie International Fellowship
- Italian Ministry of Research
- PRIN
- Fondazione A.R.C.O.
- Fondazione Arpa
Background: This multicenter study evaluated three candidate microRNAs (miRNAs) (miR-21, miR-155 and miR-101) as potential biomarkers in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. Patients and methods: miRNA expression was quantified by quantitative AT-FOR in 86 laser-microdissected specimens, including 65 invasive IPMNs, 16 non-invasive IPMNs and 5 normal pancreatic ductal tissues. Univariate and multivariate analyses compared miRNAs and clinical parameters with overall (OS) and disease-free survival (DFS). Results: miR-21 and miR-155 were up-regulated in invasive IPMNs compared with non-invasive IPMNs, as well as in non-invasive IPMNs compared with normal tissues. Conversely, miR-101 levels were significantly higher in non-invasive IPMNs and normal tissues compared with invasive IPMNs. High levels of miR-21 were associated with worse OS [hazard ratio (HR) = 2.47, 95% confidence interval (CI) = 1.37-5.65, P = 0.0047]. Patients with high-miR-21 expression also had a shorter median DFS (10.9 versus 29.9 months, P = 0.01). Multivariate analysis confirmed miR-21 as independently prognostic for mortality and disease progression (death risk: HR =3.3, 95% CI = 1.5-7.0, P = 0.02; progression risk: HR = 2.3, 95% Cl = 1.2-4.8, P = 0.02), as well as positive lymph-node status (death risk: HR = 2.6, 95% CI P = 0.03; progression risk: HR = 2.2, 95% CI = 1.0-4.8, P = 0.04). Conclusions: miR-21, miR-155 and miR-101 showed significant differences in invasive versus non-invasive IPMNs. miR-21 emerged as an independent prognostic biomarker in invasive IPMNs and should be validated in prospective studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据